Trilogy Capital Inc. Q2 2018 Filing

Filed August 20, 2018

Portfolio Value

$743.2B

Holdings

617

Report Date

Q2 2018

Filing Type

13F-HR

All Holdings (617 positions)

#StockSharesValue% PortfolioType
601
REXAHN PHARMACEUTICALS INC
200$00.00%
602
INVESCO EXCHANGE TRADED FD T
10$00.00%
603
CEIXEURCONSOL ENERGY INC NEW
2$00.00%
604
GDXVANECK VECTORS ETF TR
20$00.00%
605
VDEVANGUARD WORLD FDS
4$00.00%
606
SYNERGY PHARMACEUTICALS DEL
200$00.00%
607
FRONTLINE LTD
5$00.00%
608
FRONTIER COMMUNICATIONS CORP
22$00.00%
609
GCI LIBERTY INC
9$00.00%
610
DVNDEVON ENERGY CORP NEW
10$00.00%
611
FLEXFLEX LTD
33$00.00%
612
ADNTADIENT PLC
1$00.00%
613
VIVUS INC
100$00.00%
614
NEENEXTERA ENERGY INC
2$00.00%
615
FWONALIBERTY MEDIA CORP DELAWARE
5$00.00%
616
EWYISHARES INC
6$00.00%
617
MNSTMONSTER BEVERAGE CORP NEW
8$00.00%
PreviousPage 7 of 7